ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 135 filers reported holding ANTARES PHARMA INC in Q3 2019. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,129,000 | +196.3% | 275,284 | +188.2% | 0.00% | 0.0% |
| Q4 2020 | $381,000 | -39.6% | 95,522 | -59.1% | 0.00% | -50.0% |
| Q3 2020 | $631,000 | -53.5% | 233,727 | -52.7% | 0.00% | -60.0% |
| Q2 2020 | $1,357,000 | -30.3% | 493,821 | -40.1% | 0.01% | -47.4% |
| Q1 2020 | $1,947,000 | -39.9% | 825,061 | +19.8% | 0.02% | -13.6% |
| Q4 2019 | $3,237,000 | +173.4% | 688,621 | +94.3% | 0.02% | +144.4% |
| Q3 2019 | $1,184,000 | -66.9% | 354,432 | -67.4% | 0.01% | -69.0% |
| Q2 2019 | $3,582,000 | -45.7% | 1,088,657 | -50.0% | 0.03% | -6.5% |
| Q1 2019 | $6,600,000 | +122.9% | 2,177,754 | +100.0% | 0.03% | +3.3% |
| Q4 2018 | $2,961,000 | +765.8% | 1,088,657 | +968.1% | 0.03% | +2900.0% |
| Q3 2018 | $342,000 | – | 101,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |